Do Minh Ngo, An Thi Binh Nguyen, Hanh Duc Nguyen, Hau Van Hoang
{"title":"越南国立肺病医院耐药结核病住院患者的直接医疗费用：一项为期一年的研究。","authors":"Do Minh Ngo, An Thi Binh Nguyen, Hanh Duc Nguyen, Hau Van Hoang","doi":"10.1177/22799036261467454","DOIUrl":null,"url":null,"abstract":"<p><strong>Abstract: </strong>Drug-resistant tuberculosis remains a major global public health challenge due to its complex treatment regimens and prolonged treatment duration. Drug-resistant tuberculosis treatment requires more expensive second-line medications, intensive monitoring, and longer hospitalization, resulting in substantially higher healthcare costs. Vietnam is one of 30 countries with a high burden of tuberculosis and drug-resistant tuberculosis.</p><p><strong>Objective: </strong>This study aims to investigate direct medical costs and associated factors of the costs in drug-resistant tuberculosis inpatients.</p><p><strong>Methods: </strong>A retrospective study was conducted at the National Lung Hospital. Medical and financial data of 629 inpatients with drug-resistant tuberculosis inpatients who discharged from the hospital from January 1st to December 31st, 2024, were collected.</p><p><strong>Results: </strong>The median of total inpatient treatment cost for a hospital stay was $707.2, and costs of drugs and intravenous fluids accounted for the highest proportion (38%) of total costs. Length of stays, number of comorbidities, and age were independent predictors of increased the direct medical costs of drug-resistant tuberculosis inpatients.</p><p><strong>Conclusions: </strong>Treatment costs for DR-TB in Vietnam remain high, highlighting the need for targeted financial support for vulnerable patients.</p>","PeriodicalId":45958,"journal":{"name":"Journal of Public Health Research","volume":"15 3","pages":"22799036261467454"},"PeriodicalIF":2.1000,"publicationDate":"2026-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13459660/pdf/","citationCount":"0","resultStr":"{\"title\":\"Direct medical costs for drug-resistant tuberculosis inpatients at the national lung hospital, Vietnam: A one-year study.\",\"authors\":\"Do Minh Ngo, An Thi Binh Nguyen, Hanh Duc Nguyen, Hau Van Hoang\",\"doi\":\"10.1177/22799036261467454\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Abstract: </strong>Drug-resistant tuberculosis remains a major global public health challenge due to its complex treatment regimens and prolonged treatment duration. Drug-resistant tuberculosis treatment requires more expensive second-line medications, intensive monitoring, and longer hospitalization, resulting in substantially higher healthcare costs. Vietnam is one of 30 countries with a high burden of tuberculosis and drug-resistant tuberculosis.</p><p><strong>Objective: </strong>This study aims to investigate direct medical costs and associated factors of the costs in drug-resistant tuberculosis inpatients.</p><p><strong>Methods: </strong>A retrospective study was conducted at the National Lung Hospital. Medical and financial data of 629 inpatients with drug-resistant tuberculosis inpatients who discharged from the hospital from January 1st to December 31st, 2024, were collected.</p><p><strong>Results: </strong>The median of total inpatient treatment cost for a hospital stay was $707.2, and costs of drugs and intravenous fluids accounted for the highest proportion (38%) of total costs. Length of stays, number of comorbidities, and age were independent predictors of increased the direct medical costs of drug-resistant tuberculosis inpatients.</p><p><strong>Conclusions: </strong>Treatment costs for DR-TB in Vietnam remain high, highlighting the need for targeted financial support for vulnerable patients.</p>\",\"PeriodicalId\":45958,\"journal\":{\"name\":\"Journal of Public Health Research\",\"volume\":\"15 3\",\"pages\":\"22799036261467454\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2026-07-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13459660/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Public Health Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/22799036261467454\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2026/7/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Public Health Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/22799036261467454","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/7/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
Direct medical costs for drug-resistant tuberculosis inpatients at the national lung hospital, Vietnam: A one-year study.
Abstract: Drug-resistant tuberculosis remains a major global public health challenge due to its complex treatment regimens and prolonged treatment duration. Drug-resistant tuberculosis treatment requires more expensive second-line medications, intensive monitoring, and longer hospitalization, resulting in substantially higher healthcare costs. Vietnam is one of 30 countries with a high burden of tuberculosis and drug-resistant tuberculosis.
Objective: This study aims to investigate direct medical costs and associated factors of the costs in drug-resistant tuberculosis inpatients.
Methods: A retrospective study was conducted at the National Lung Hospital. Medical and financial data of 629 inpatients with drug-resistant tuberculosis inpatients who discharged from the hospital from January 1st to December 31st, 2024, were collected.
Results: The median of total inpatient treatment cost for a hospital stay was $707.2, and costs of drugs and intravenous fluids accounted for the highest proportion (38%) of total costs. Length of stays, number of comorbidities, and age were independent predictors of increased the direct medical costs of drug-resistant tuberculosis inpatients.
Conclusions: Treatment costs for DR-TB in Vietnam remain high, highlighting the need for targeted financial support for vulnerable patients.
期刊介绍：
The Journal of Public Health Research (JPHR) is an online Open Access, peer-reviewed journal in the field of public health science. The aim of the journal is to stimulate debate and dissemination of knowledge in the public health field in order to improve efficacy, effectiveness and efficiency of public health interventions to improve health outcomes of populations. This aim can only be achieved by adopting a global and multidisciplinary approach. The Journal of Public Health Research publishes contributions from both the “traditional'' disciplines of public health, including hygiene, epidemiology, health education, environmental health, occupational health, health policy, hospital management, health economics, law and ethics as well as from the area of new health care fields including social science, communication science, eHealth and mHealth philosophy, health technology assessment, genetics research implications, population-mental health, gender and disparity issues, global and migration-related themes. In support of this approach, JPHR strongly encourages the use of real multidisciplinary approaches and analyses in the manuscripts submitted to the journal. In addition to Original research, Systematic Review, Meta-analysis, Meta-synthesis and Perspectives and Debate articles, JPHR publishes newsworthy Brief Reports, Letters and Study Protocols related to public health and public health management activities.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
